Literature DB >> 22909176

OCT findings in birdshot chorioretinitis: a glimpse into retinal disease evolution.

Marina Papadia1, Bruno Jeannin, Carl P Herbort.   

Abstract

BACKGROUND AND
OBJECTIVE: Birdshot chorioretinitis is a rare disease independently involving the retina and the choroid. Retinal involvement has deleterious functional consequences. This study aimed to follow retinal profiles in early (< 1 year, untreated), intermediate (1 to 6 years, receiving therapy), and late (> 6 years) birdshot chorioretinitis. PATIENTS AND METHODS: Optical coherence tomography images were retrospectively evaluated in 28 eyes and retinal thickness was calculated in the foveola, parafoveal nasal, and temporal area; nasal and temporal mid-peripheral macula; and nasal and temporal periphery of the macula.
RESULTS: Retinal thickness was significantly elevated in early birdshot chorioretinitis because of diffuse exudative retinal vasculopathy. In late disease, retinal thickness was significantly thinned at all measured locations compared with early disease. Epiretinal membrane development was observed in 92% of eyes with late birdshot chorioretinitis.
CONCLUSION: The retina is thickened and exudative in early birdshot chorioretinitis, thickness diminishes during intermediate birdshot chorioretinitis, and retinal thinning/atrophy with a high rate of epiretinal membrane is observed in late birdshot chorioretinitis. Copyright 2012, SLACK Incorporated.

Entities:  

Mesh:

Year:  2012        PMID: 22909176     DOI: 10.3928/15428877-20120816-01

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging        ISSN: 1542-8877


  12 in total

1.  Feasibility of swept-source OCT for active birdshot chorioretinopathy.

Authors:  Olga Garcia-Garcia; Sara Jordan-Cumplido; Olaia Subira-Gonzalez; Pere Garcia-Bru; Luis Arias; Josep M Caminal-Mitjana
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-05-03       Impact factor: 3.117

Review 2.  New concepts in the appraisal and management of birdshot retinochoroiditis, a global perspective.

Authors:  Marina Papadia; Carl P Herbort
Journal:  Int Ophthalmol       Date:  2015-02-14       Impact factor: 2.031

3.  Contribution of dual fluorescein and indocyanine green angiography to the appraisal of posterior involvement in birdshot retinochoroiditis and Vogt-Koyanagi-Harada disease.

Authors:  Ozlem Balci; Bruno Jeannin; Carl P Herbort
Journal:  Int Ophthalmol       Date:  2017-03-15       Impact factor: 2.031

4.  Early and sustained treatment modifies the phenotype of birdshot retinochoroiditis.

Authors:  Pascal B Knecht; Marina Papadia; Carl P Herbort
Journal:  Int Ophthalmol       Date:  2013-10-01       Impact factor: 2.031

Review 5.  Advances and potential new developments in imaging techniques for posterior uveitis. Part 1: noninvasive imaging methods.

Authors:  Ilknur Tugal-Tutkun; Carl P Herbort; Alessandro Mantovani; Piergiorgio Neri; Moncef Khairallah
Journal:  Eye (Lond)       Date:  2020-07-16       Impact factor: 3.775

Review 6.  Mechanisms, Pathophysiology and Current Immunomodulatory/Immunosuppressive Therapy of Non-Infectious and/or Immune-Mediated Choroiditis.

Authors:  Ioannis Papasavvas; Ilknur Tugal-Tutkun; Carl P Herbort
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-24

7.  Why birdshot retinochoroiditis should rather be called 'HLA-A29 uveitis'?

Authors:  Carl P Herbort; Carlos Pavésio; Phuc LeHoang; Bahram Bodaghi; Christine Fardeau; Philippe Kestelyn; Piergiorgio Neri; Marina Papadia
Journal:  Br J Ophthalmol       Date:  2017-03-17       Impact factor: 4.638

Review 8.  Classification of Non-Infectious and/or Immune Mediated Choroiditis: A Brief Overview of the Essentials.

Authors:  Carl P Herbort; Alessandro Mantovani; Ilknur Tugal-Tutkun; Ioannis Papasavvas
Journal:  Diagnostics (Basel)       Date:  2021-05-24

Review 9.  Birdshot uveitis: current and emerging treatment options.

Authors:  Victor Menezo; Simon Rj Taylor
Journal:  Clin Ophthalmol       Date:  2013-12-18

10.  Evolution of choroidal thickness over time and effect of early and sustained therapy in birdshot retinochoroiditis.

Authors:  N Skvortsova; A Gasc; B Jeannin; C P Herbort
Journal:  Eye (Lond)       Date:  2017-04-21       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.